Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 31, 2015 6:29 AM ET

Company Overview of Universita' degli Studi di Torino

Company Overview

University of Turin Italy is an educational institution.

Via Verdi

Torino,  

Italy

Key Executives for Universita' degli Studi di Torino

Universita' degli Studi di Torino does not have any Key Executives recorded.

Universita' degli Studi di Torino Key Developments

Multiple Myeloma Research Foundation, University of Torino and Adaptive Biotechnologies Work to Speed Novel Minimal Residual Disease Monitoring Technologies to Patients

The Multiple Myeloma Research Foundation (MMRF), in collaboration with the University of Torino (UofT) and Adaptive Biotechnologies, announced a collaboration to perform sequencing-based assessment of minimal residual disease (MRD) on hundreds of multiple myeloma (MM) patients over a five year period. The purpose of this initiative is to investigate a new approach to monitoring MRD. This collaboration, partially supported by Amgen, will be part of the INSIDE MM-1 study, led by Professor Antonio Palumbo from UofT. Professor Palumbo presented promising results of an earlier study at the 2013 American Society for Clinical Oncology (ASCO) annual meeting. This earlier study, funded by a 2010 Diagnostics Investment Award from the MMRF, set the stage for INSIDE MM-1, a groundbreaking, comparative, clinical disease monitoring trial. More than 400 newly diagnosed MM patients will be enrolled in INSIDE MM-1 and will receive a combination of carfilzomib and lenalidomide, followed by a bone marrow transplant with or without maintenance. Patients will be monitored for MRD using both flow cytometry and Adaptive Biotechnologies’ clonoSEQ MRD test at regular intervals from initial diagnosis for up to five years after initial treatment.

Universita' degli Studi di Torino Presents at The Euromoney London Islamic Finance and Investment Conference, Feb-11-2015 11:40 AM

Universita' degli Studi di Torino Presents at The Euromoney London Islamic Finance and Investment Conference, Feb-11-2015 11:40 AM. Venue: Marriott, Grosvenor Square, London, W1K 6JP, United Kingdom. Speakers: Paolo Pietro Biancone, Editor in Chief.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Universita degli Studi di Torino, please visit www.unito.it. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.